Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Intangibles (2021 - 2025)

LifeStance Health (LFST) has disclosed Intangibles for 5 consecutive years, with $184.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Intangibles fell 8.04% to $184.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $184.0 million, a 8.04% decrease, with the full-year FY2024 number at $190.8 million, down 13.69% from a year prior.
  • Intangibles was $184.0 million for Q2 2025 at LifeStance Health, down from $190.8 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $316.5 million in Q2 2021 to a low of $184.0 million in Q2 2025.
  • A 5-year average of $234.3 million and a median of $227.3 million in 2023 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: decreased 17.94% in 2024, then fell 8.04% in 2025.
  • LifeStance Health's Intangibles stood at $300.4 million in 2021, then fell by 12.34% to $263.3 million in 2022, then decreased by 16.04% to $221.1 million in 2023, then dropped by 13.69% to $190.8 million in 2024, then fell by 3.58% to $184.0 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Intangibles are $184.0 million (Q2 2025), $190.8 million (Q4 2024), and $195.4 million (Q3 2024).